Abstract
The development of novel biointeractive hydrogels for tissue engineering1–3, tissue repair, and release of drugs4 and growth factors5 has attracted considerable attention over the past decade. Our attention has focused on hydrogels based on the extracellular matrix (ECM), a heterogeneous collection of covalent and noncovalent molecular interactions comprised primary of proteins and glycosaminoglycans (GAGs)6. In the ECM, covalent interactions connect chondroitin sulfate (CS), heparan sulfate (HS) and other sulfated GAGs to core proteins forming proteoglycans (PGs). Noncovalent interactions include binding of link modules of PGs to hyaluronan (HA), electrostatic associations with ions, hydration of the polysaccharide chains, and triple helix formation to generate collagen fibrils.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
9.5. References
Lee, K. & Mooney, D. Hydrogels for tissue engineering. Chem. Rev. 101, 1869–1879 (2001).
Sakiyama-Elbert, S. & Hubbell, J.A. Functional biomaterials: design of novel biomaterials. Annu. Rev. Mater. Res. 31, 183–201 (2001).
Anseth, K.S. et al. In situ forming degradable networks and their application in tissue engineering and drug delivery. J. Control. Release 78, 199–209 (2002).
Langer, R. Biomaterial in drug delivery and tissue engineering: one laboratory’s experience. Acc. Chem. Res. 33, 94–101 (2000).
Lee, K.Y., Peters, M.C., Anderson, K.W. & Mooney, D.J. Controlled growth factor release from synthetic extracellular matrices. Nature 408, 998–1000 (2000).
Knudson, C.B. & Knudson, W. Cartilage proteoglycans. Semin. Cell Dev. Biol. 12, 69–78 (2001).
Toole, B.P. Hyaluronan in morphogenesis. Semin. Cell Dev. Biol. 12, 79–87 (2001).
Prestwich, G.D. et al. Chemically modified hyaluronan: New biomaterials and probes for cell biology. in New Frontiers in Medical Sciences: Redefining Hyaluronan (ed. Weigel, P.H.) 181–194 (Elsevier Science, Padua, Italy, 2000).
Vercruysse, K.P. & Prestwich, G.D. Hyaluronate derivatives in drug delivery. Crit. Rev. Ther. Drug Carr. Syst. 15, 513–555 (1998).
Luo, Y. & Prestwich, G.D. Novel biomaterials for drug delivery. Exp. Opin. Ther. Patents 11, 1395–1410 (2001).
Luo, Y. & Prestwich, G.D. Cancer-targeted polymeric drugs. Curr. Cancer Drug Targ. 2, 209–226 (2002).
Prestwich, G.D. Biomaterials from chemically-modified hyaluronan. Glycoforum http://glycoforum.gr.jp/science/hyaluronan/HA18/HA18E.html (2001).
Shu, X.Z. & Prestwich, G.D. Therapeutic biomaterials from chemically modified hyaluronan. in Chemistry and Biology of Hyaluronan (ed. Hales, C.A.) 475–504 (Elsevier Press, Amsterdam, 2004).
Shu, X.Z., Liu, Y., Palumbo, F., Luo, Y. & Prestwich, G.D. In situ crosslinkable glycosaminoglycan hydrogels for tissue engineering. Biomaterials 25, 1139–1348 (2004).
Kirker, K.R., Luo, Y., Nielson, J.H., Shelby, J. & Prestwich, G.D. Glycosaminoglycan hydrogel films as biointeractive dressings for wound healing. Biomaterials 23, 3661–3671 (2002).
Kirker, K.R., Luo, Y., Morris, S.E., Shelby, J. & Prestwich, G.D. Glycosaminoglycan hydrogel films as supplemental wound dressings for donor sites. J. Burn Care Rehabil. 25, 276–286 (2004).
Proctor, M. et al. Composition of hyaluronan affects wound healing in the rabbit maxillary sinus. Am. J. Rhinology, in press (2005).
Gilbert, M.E. et al. Chrondroitin sulfate hydrogel and wound healing in rabbit maxillary sinus mucosa. Laryngoscope 114, 1406–1409 (2004).
Liu, Y., Li, H., Shu, X.Z., Gray, S.D. & Prestwich, G.D. Crosslinked hyaluronan hydrogels containing mitomycin C reduce post-operative abdominal adhesions. Fertil. & Steril. 83, 1275–1283 (2005).
Hansen, J.K., Thibeault, S.L., Walsh, J.F., Shu, X.Z. & Prestwich, G.D. In vivo engineering of the vocal fold ECM with injectable HA hydrogels: Early effects on tissue repair and biomechanics in a rabbit model. Ann. Otol. Rhinol. Laryngol. 114, 662–670 (2005).
Sondrup, C., Liu, Y., Shu, X.Z., Prestwich, G.D. & Smith, M.E. Bioactive stents in the prevention of airway stenosis. Otolaryngol. Head & Neck Surg., in press (2005).
Pouyani, T. & Prestwich, G.D. Functionalized derivatives of hyaluronic acid oligosaccharides: Drug carriers and novel biomaterials. Bioconjugate Chem. 5, 339–347 (1994).
Pouyani, T., Harbison, G.S. & Prestwich, G.D. Novel hydrogels of hyaluronic acid: Synthesis, surface morphology, and solid-state NMR. J. Am. Chem. Soc. 116, 7515–7522 (1994).
Vercruysse, K.P., Marecak, D.M., Marecek, J.F. & Prestwich, G.D. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjugate Chem. 8, 686–694 (1997).
Shu, X.Z., Liu, Y., Luo, Y., Roberts, M.C. & Prestwich, G.D. Disulfide crosslinked hyaluronan hydrogels. Biomacromolecules 3, 1304–1311 (2002).
Liu, Y., Shu, X.Z. & Prestwich, G.D. Biocompatibility and stability of disulfide-crosslinked hyaluronan films. Biomaterials 26, 4737–4746 (2005).
Ghosh, K. et al. Rheological characterization of in situ crosslinkable hyaluronan hydrogels. Biomacromolecules 6, 2857–2865 (2005).
Shu, X.Z., Liu, Y., Palumbo, F. & Prestwich, G.D. Disulfide-crosslinked hyaluronan-gelatin hydrogel films: A covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials 24, 3825–3834 (2003).
Shu, X.Z. et al. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J. Biomed. Mat. Res. 68A, 365–375 (2004).
Ghosh, K., Ren, X.-D., Shu, X.Z., Prestwich, G.D. & Clark, R.A.F. Fibronectin functional domains coupled to hyaluronan stimulate primary human dermal fibroblast responses critical for wound healing. Tissue Eng., in press (2005).
Peattie, R.A. et al. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials 25, 2789–2798 (2004).
Peattie, R.A. et al. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. Biomaterials, 27, 1868–1875 (2006).
Cai, S., Liu, Y., Shu, X.Z. & Prestwich, G.D. Injectable glycosaminoglycan hydrogels for controlled release of basic fibroblast growth factor. Biomaterials 26, 6054–6067 (2005).
Mironov, V. et al. Fabrication of tubular tissue construct by centrifugal casting of cells suspended in an in situ crosslinkable hyaluronan hydrogel. Biomaterials 26, 7628–7635 (2005).
Prestwich, G.D., Liu, Y., Shu, X.Z. & Xu, Y. 3-D culture of tumors in vitro and in vivo in a synthetic extracellular matris. in American Association for Cancer Research (Anaheim, CA, 2005).
Li, H., Liu, Y., Shu, X.Z., Gray, S.D. & Prestwich, G.D. Synthesis and biological evaluation of a crosslinked hyaluronan-mitomycin C hydrogel. Biomacromolecules 5, 895–902 (2004).
Duflo, S., Thibeault, S.L., Li, W., Shu, X.Z. & Prestwich, G.D. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng., in press (2005).
Liu, Y. et al. Accelerated repair of cortical bone defects using a synthetic extracellular matrix to deliver human demineralized bone matrix. J. Orthoped. Res., in press (2005).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Prestwich, G.D. et al. (2006). Injectable Synthetic Extracellular Matrices for Tissue Engineering and Repair. In: Fisher, J.P. (eds) Tissue Engineering. Advances in Experimental Medicine and Biology, vol 585. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-34133-0_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-34133-0_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32664-1
Online ISBN: 978-0-387-34133-0
eBook Packages: EngineeringEngineering (R0)